Get the Stockscreener App
237.87
0.61%
1.3812
Veeva Systems Inc stock is traded at $237.87, with a volume of 74,876.
It is up +0.61% in the last 24 hours and up +11.35% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$236.49
Open:
$235.3
24h Volume:
74,876
Relative Volume:
0.06
Market Cap:
$36.73B
Revenue:
$2.75B
Net Income/Loss:
$714.14M
P/E Ratio:
54.94
EPS:
4.33
Net Cash Flow:
$1.09B
1W Performance:
+5.39%
1M Performance:
+11.35%
6M Performance:
+11.89%
1Y Performance:
+16.95%
1-Day Range:
$234.75
$238.16
1-Week Range:
$226.51
$238.16
52-Week Range:
$170.25
$258.93
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
237.49 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.39 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.08 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
91.32 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.94 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Downgrade | Goldman | Buy → Sell |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-19-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
| Aug-27-24 | Reiterated | Citigroup | Buy |
| Jul-09-24 | Initiated | BTIG Research | Buy |
| Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-23 | Initiated | Jefferies | Buy |
| Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Truist | Buy → Hold |
| Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-06-22 | Initiated | Cowen | Market Perform |
| Dec-02-22 | Reiterated | Needham | Buy |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-27-22 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | Goldman | Buy |
| Jun-21-22 | Resumed | Guggenheim | Buy |
| Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-28-22 | Initiated | Truist | Buy |
| Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Resumed | Stifel | Buy |
| Sep-02-21 | Reiterated | BofA Securities | Buy |
| Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-02-21 | Reiterated | Needham | Buy |
| Sep-02-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Initiated | Cowen | Outperform |
| Mar-31-21 | Upgrade | UBS | Sell → Neutral |
| Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
| Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-14-20 | Resumed | UBS | Sell |
| Aug-28-20 | Reiterated | Needham | Buy |
| Jul-23-20 | Initiated | FBN Securities | Outperform |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Jun-08-20 | Initiated | Citigroup | Buy |
| May-29-20 | Reiterated | Needham | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-19-20 | Initiated | Robert W. Baird | Outperform |
| Feb-14-20 | Initiated | Piper Sandler | Overweight |
| Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
| Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-28-19 | Reiterated | Needham | Buy |
| Jun-07-19 | Initiated | Goldman | Neutral |
| May-30-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - MSN
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Benzinga
Veeva Systems (NYSE:VEEV) Unveils Veeva AI To Boost Productivity In Life Sciences - Yahoo Finance
Werner Engelbrecht - AI Business
Veeva Systems (VEEV) Introduces Veeva AI to Enhance Life Science - GuruFocus
Veeva Systems Introduces Veeva AI - Contract Pharma
Announcing Veeva AI | VEEV Stock News - GuruFocus
Announcing Veeva AI - Financial Times
Here's Why You Should Add Veeva Stock to Your Portfolio Now - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Peering Into Veeva Systems's Recent Short Interest - Benzinga
Veeva (VEEV) Price Target Trimmed by Piper Sandler Amid Industry Challenges | VEEV Stock News - GuruFocus
Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network - Yahoo Finance
Life Science Data Needs an Upgrade: Veeva Has Answers - Fierce Pharma
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock - MSN
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy? - Yahoo Finance
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next - The Motley Fool
Veeva Systems: Substantially Overvalued As Growth Slows (NYSE:VEEV) - Seeking Alpha
Veeva Systems (NYSE:VEEV) Partners With Flatiron To Enhance Clinical Trial Data Efficiency - Yahoo Finance
Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research - Business Wire
Q4 Earnings Outperformers: Veeva Systems (NYSE:VEEV) And The Rest Of The Vertical Software Stocks - Yahoo Finance
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Veeva Systems’ chief customer officer sells $265,168 in stock By Investing.com - Investing.com India
Veeva Systems’ chief customer officer sells $265,168 in stock - Investing.com
4 Ways Top Sponsors Build Strong and Sustainable Site Relationships - Veeva
Investors Interested In Veeva Systems Inc.'s (NYSE:VEEV) Earnings - simplywall.st
Improve Safety Outputs, Oversight, and Data Quality with In-house Pharmacovigilance Solution - Veeva
B. Braun Transforms Global Clinical Trial Management for Digital Excellence - Veeva
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? - Nasdaq
eClinical Solutions Market Top PlayersMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
ACELYRIN Optimizes the Sponsor-CRO Data Flow with a Centralized Clinical Data Workbench - Veeva
Veeva Systems director Timothy Cabral sells $841,734 in stock By Investing.com - Investing.com Canada
Veeva Systems director Timothy Cabral sells $841,734 in stock - Investing.com
Veeva Systems (VEEV) Gains As Market Dips: What You Should Know - Yahoo Finance
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report? - Yahoo Finance
Veeva Systems (VEEV) Benefited in Q4 From Strong Execution - Insider Monkey
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know - MSN
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks - Yahoo Finance
Best Momentum Stocks to Buy for April 3rd - TradingView
Veeva Systems Inc. (NYSE:VEEV) Receives $256.52 Average PT from Brokerages - MarketBeat
Veeva Systems SVP sells shares worth $178,019 - Investing.com Australia
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It? - MSN
Veeva Systems SVP sells shares worth $178,019 By Investing.com - Investing.com Canada
We Think Veeva Systems' (NYSE:VEEV) Profit Is Only A Baseline For What They Can Achieve - Yahoo
VEEV Stock Slips Despite New Research Site Clinical Trial System - Yahoo Finance
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):